Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1, Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, 400016, China.
Department of Breast Surgery, The First People's Hospital of Yibin, Yibin, Sichuan, China.
Clin Transl Oncol. 2019 Sep;21(9):1207-1219. doi: 10.1007/s12094-019-02042-w. Epub 2019 Feb 14.
Although it has been well established that G protein plays pivotal roles in physiologic or pathologic conditions, including cancer formation, its role in breast cancer, especially specific subunits, remains largely unknown. Our work aimed to evaluate the correlation of the G protein alpha subunit (GNAS) with breast cancer and to investigate the underlying molecular mechanism.
The expression of GNAS was determined by breast tumor tissue microarray of 150 patients with complete follow-up information. The correlation between GNAS expression and clinical features was assessed. CCK8, EdU incorporation, flow cytometry, wound healing, transwell, western blot and tumor formation assays were carried out in nude mice to study the biological function of GNAS and the underlying molecular mechanism in breast cancer by silencing GNAS using a specific siRNA.
High GNAS expression showed a close correlation with a reduced overall survival (p = 0.021), frequent distal metastasis (p = 0.026), advanced clinical stage (p = 0.001), stronger cell proliferation (ki67 positive cell rate, p = 0.0351) and enhanced cancer cell migration, which was further confirmed by in vitro and in vivo assays and might be dependent on the PI3K/AKT/Snail1/E-cadherin axis.
The data suggested that GNAS promoted breast cancer cell proliferation and migration (EMT) through the PI3K/AKT/Snail1/E-cadherin signaling pathway. These findings also indicate that GNAS can serve as a potential prognostic indicator and novel therapeutic target in breast cancer.
尽管已经充分证实 G 蛋白在生理或病理条件下(包括癌症形成)发挥关键作用,但它在乳腺癌中的作用,尤其是特定亚基,仍知之甚少。我们的工作旨在评估 G 蛋白α亚基(GNAS)与乳腺癌的相关性,并研究其潜在的分子机制。
通过对 150 例具有完整随访信息的乳腺癌组织微阵列,测定 GNAS 的表达。评估 GNAS 表达与临床特征的相关性。在裸鼠中进行 CCK8、EdU 掺入、流式细胞术、划痕愈合、Transwell、western blot 和肿瘤形成实验,通过使用特异性 siRNA 沉默 GNAS 来研究 GNAS 在乳腺癌中的生物学功能及其潜在的分子机制。
高 GNAS 表达与总生存期缩短(p=0.021)、远处转移频繁(p=0.026)、临床分期较晚(p=0.001)、更强的细胞增殖(ki67 阳性细胞率,p=0.0351)和增强的癌细胞迁移密切相关,这进一步通过体外和体内实验得到证实,并且可能依赖于 PI3K/AKT/Snail1/E-cadherin 轴。
数据表明,GNAS 通过 PI3K/AKT/Snail1/E-cadherin 信号通路促进乳腺癌细胞增殖和迁移(EMT)。这些发现还表明,GNAS 可以作为乳腺癌潜在的预后标志物和新型治疗靶点。